Related Experiment Video

Updated: Jul 4, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.6K

New Horizon of Multiple System Atrophy Research

Shoji Tsuji1,2, Gregor Wenning3

  • 1Institute of Medical Genomics, International University of Health and Welfare, 4-3, Kozunomori, Chiba, 286-8686, Japan. tsuji@m.u-tokyo.ac.jp.

Cerebellum (London, England)
|February 2, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Clinical trialDisease-modifying treatmentMolecular geneticsMultiple system atrophyα-synuclein

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.3K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547